Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
03/12/2008 | EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
03/12/2008 | EP0972048B1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
03/12/2008 | CN101142219A Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof |
03/12/2008 | CN101141972A Gastrointestinal drug composition |
03/12/2008 | CN101141954A Gastrointestinal motor activation regulator |
03/12/2008 | CN101139345A Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
03/12/2008 | CN101139343A Synthesis of piperidine and piperazine compounds as ccr5 antagonists |
03/12/2008 | CN101138623A Medicament for preventing and treating deficiency of the kidney essence |
03/12/2008 | CN101138622A Prescription of mouth ulcer bilayer film and technique of preparing the same |
03/12/2008 | CN101138621A Pharmaceutical composition for gestation reaction and method of preparing the same |
03/12/2008 | CN101138617A Multiple-effect paste for activating blood circulation and removing stasis |
03/12/2008 | CN101138616A Prescription for treating tummy bug |
03/12/2008 | CN101138610A Chinese medicinal herb prescription for treating dental disease and preparation method thereof |
03/12/2008 | CN101138609A Prescription of Chinese yam lozenge |
03/12/2008 | CN101138606A Chinese medicinal herb for treating dyspepsodynia |
03/12/2008 | CN101138603A Pure Chinese traditional medicine granular preparation for treating gastroesophageal reflux disease |
03/12/2008 | CN101138598A Health medicinal beverage vinegar and method of preparing the same |
03/12/2008 | CN101138596A Prescription of traditional Chinese medicine hyssop health lozenge |
03/12/2008 | CN101138586A Riboflavin natural indigo mouth ulcer paster |
03/12/2008 | CN101138583A Acupoint medicament for treating hepatopathy |
03/12/2008 | CN101138573A Application of clostridium butyricum and condensate bacillus in the preparation of medicament for treating inflammatory bowel disease |
03/12/2008 | CN101138572A Medicament for treating children lax |
03/12/2008 | CN101138566A Prevention and treatment process for infectious diseases and other diseases by using immunity effect compounds |
03/12/2008 | CN101138563A Pharmaceutical composition for treating peptic ulcer |
03/12/2008 | CN101138541A Amlexanox partial film forming gel composition and uses thereof |
03/12/2008 | CN100374538C Fire internal organ nourishing wine and its preparation technology |
03/12/2008 | CN100374466C Antibodies against human IL-12 |
03/12/2008 | CN100374461C Glucagon-like peptide-2 and its therapeutic use |
03/12/2008 | CN100374159C Preventives or remedies for inflammatory intestinal diseases contg. as active ingredient IL-6 antagonists |
03/12/2008 | CN100374156C Health products for face care and body care |
03/12/2008 | CN100374154C Sincalide formulations |
03/12/2008 | CN100374148C Oral liquid for preventing and treating diarrhea |
03/12/2008 | CN100374144C Chinese medicinal oral liquid for treating appendicitis and enteritis |
03/12/2008 | CN100374137C Beautifying and spot eliminating health care product and its prepn process |
03/12/2008 | CN100374136C Hairy antler capsules |
03/12/2008 | CN100374125C Pharmaceutical compsn. contg. extract from barleria prionitis linn and its process of prepn |
03/12/2008 | CN100374122C Calf serum deprotein oral cavity ointment and its preparation method |
03/12/2008 | CN100374118C Drip pill agent containing adefovir divoxil and its preparing method |
03/12/2008 | CN100374105C Glabrous sarcandra herb lyophilized powder for injection, its high-dose injection and preparing method |
03/12/2008 | CN100374045C Method for preparing micron pearl particle and capsule for assisting sleep, tonifying intestine and supplying calcium |
03/12/2008 | CN100374040C Bamboo salt preparation method |
03/12/2008 | CN100374030C Method for preparing micron pearl soybean milk taken at night for assisting sleep, tonifying intestine and supplying calcium |
03/12/2008 | CN100374029C Method for preparing micron pearl soybean milk powder taken at night for assisting sleep, tonifying intestine and supplying calcium |
03/11/2008 | US7342105 Antibody and use thereof |
03/11/2008 | US7342032 Psychiatric and neurological disorders; cannabinoid (cb1) receptor; such as 4-(4-Chlorophenyl)-5-(2,4-dichlorophenyl)-N-(1-piperidinyl)thiazole-2-carboxamide |
03/11/2008 | US7342029 Substituted indoles |
03/11/2008 | US7342028 Medical use for tachykinin antagonists |
03/11/2008 | US7342017 Vanilloid Receptor 1 and metabotropic glutamate receptor 1 inhibitors; inhibition of capsaicin-induced or PH-induced activation of vanilloid receptors; antidepressant; anxiolytic agent; analgesics; addictive disorders; antiemetic agent |
03/11/2008 | US7342015 Indole derivatives |
03/11/2008 | US7341995 Use of SARP-1 for the treatment and/or prevention of scleroderma |
03/11/2008 | US7341871 Recombinant expression vector comprising promoter sequence, age regulatory sequence; can use in treatment of age-related and liver diseases; operably linking nucleic acid sequence, promoter sequence, and age regulatory sequences to produce a transgene, introducing into cell |
03/11/2008 | US7341744 Administering aqueous soluble proanthocyanidin polymer isolated from a Croton species or a Calophyllum species; protective coating for oral administration |
03/11/2008 | US7341741 Using polysaccharide selected from the group consisting of xanthan gum and hydroxypropylmethylcellulose (HPMC) for therapy and prophylaxis of Crohn's Disease, left-sided ulcerative colitis or pouchitis. |
03/11/2008 | CA2335104C Arylalkanoylpyridazines |
03/11/2008 | CA2284669C Improved dasc compositions, process for preparing same and suspensions containing same |
03/11/2008 | CA2235177C New exocellular polysaccharide produced by streptococcus thermophilus |
03/06/2008 | WO2008027000A2 Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
03/06/2008 | WO2008026984A1 Topical composition comprising a dihydropyridine calcium antagonist |
03/06/2008 | WO2008026704A1 Isoquinoline derivative |
03/06/2008 | WO2008026591A1 Bactericidal agent against pathogenic bacterium of periodontal disease comprising red longhorn beetle frass as active ingredient |
03/06/2008 | WO2008026563A1 Hydrazine amide derivative |
03/06/2008 | WO2008026473A1 Method for production of hop preparation, hop preparation, antiinflammatory agent, food/beverage, and oral product |
03/06/2008 | WO2008026444A1 Aid for irrigating gastrointestinal tract comprising butyric acid bacteria and/or lactic acid bacteria |
03/06/2008 | WO2008026310A1 Protective agent for oral mucosa containing trehalose |
03/06/2008 | WO2008025926A2 Salivary substitute |
03/06/2008 | WO2008008595A3 Use of a chewing gum in a method of reducing infection |
03/06/2008 | WO2007141284A3 Treatment of gastrointestinal disorders with cgrp antagonists |
03/06/2008 | WO2007134867A3 Treating muscular disorders and improving muscular function |
03/06/2008 | WO2007133752A3 Formulations of 5-ht3 receptor antagonists with polyorthoester for use in the prevention of acute and delayed chemotherapy- induced nausea and vomiting (cinv) |
03/06/2008 | WO2007100664A3 Modulators of muscarinic receptors |
03/06/2008 | WO2007100643A3 Methods of using antibodies against human il-22 |
03/06/2008 | WO2007044032A3 Compositions having a high antiviral and antibacterial efficacy |
03/06/2008 | WO2006057755A3 Compositions containing cotinus coggygria extract and use thereof on mucosal tissues |
03/06/2008 | US20080058514 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids |
03/06/2008 | US20080058424 Novel pharmaceutical formulations of modafinil |
03/06/2008 | US20080058391 Novel compounds |
03/06/2008 | US20080058370 For treating obesity, metabolic syndrome, diabetes, hepatic lipidosis or nonalcoholic fatty liver disease; kits |
03/06/2008 | US20080058368 4,5,6,7-Tetrahydro-[1,2]Dithiolo[4,3-C] Pyridine-3-Thione Compounds |
03/06/2008 | US20080058367 Process for the purification of palonosetron or its salt |
03/06/2008 | US20080058363 Pharmaceutical composition for treating fecal incontinence and anal itch |
03/06/2008 | US20080058354 Treating erectile dysfunction and female sexual dysfunction; side effect reduction; 1-ethyl-3-(2-hydroxyethyl)-7-(3-bromo-4-methoxyphenyl)-8-(2-hydroxycyclopenylamino)-1,2,3,6-tetrahydro-7H-purine-2,6-dione for example |
03/06/2008 | US20080058314 Novel dicarboxylic acid derivatives with pharmaceutical properties |
03/06/2008 | US20080058313 Tetrahydro-2h-indazole pyrazole cannabinoid modulators |
03/06/2008 | US20080058311 Antagonizing N-type calcium channels; use as analgesic, neurodegenerative diseases, brain injury, bronchial asthma, unstable angina and irritable colitis, drug withdrawal symptoms; t-butyl 2-[4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-piperidinyl]-2-oxoethylcarbamate for example |
03/06/2008 | US20080058297 Heterocyclic Compounds For Preventing And Treating Disorders Associated With Excessive Bone Loss |
03/06/2008 | US20080057565 Method for overexpression of zwitterionic polysaccharides |
03/06/2008 | US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer |
03/06/2008 | US20080057133 Preparation of Aqueous Clear Solution Dosage Forms with Bile Acids |
03/06/2008 | US20080057109 Bifidobacterium longum infantis strain secretes a factor that antagonizes the activity ofpro-inflammatory cytokine selected from TNF- alpha, IL-8, IFN gamma to treat inflammatory bowel disease or irritable bowel syndrome |
03/06/2008 | US20080057082 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy |
03/06/2008 | US20080057047 Antibiotic Associated Diarrhea (AAD),Clostridium difficile associated diarrhea (CDAD), Inflammatory Bowel Disease (IBD) |
03/06/2008 | CA2662298A1 Topical composition comprising a dihydropyridine calcium antagonist |
03/06/2008 | CA2662083A1 Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
03/06/2008 | CA2661694A1 Salivary substitute |
03/05/2008 | EP1894564A2 Use of an ibat inhibitor for the treatment of prophylaxis of constipation |
03/05/2008 | EP1893211A1 Use of sanglifehrin in hcv |
03/05/2008 | EP1893198A2 Treatment of liver diseases in which iron plays a role in pathogenesis |
03/05/2008 | EP1893197A1 Chromane substituted benzimidazole derivatives as acid pump antagonists |
03/05/2008 | EP1713797B1 1-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide derivatives having 5-ht4 receptor agonistic activity |
03/05/2008 | EP1383733B1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |